ArticleJournal of clinical biochemistry and nutrition2026
DNA-mediated ZNF649 downregulation modulates the Hedgehog signaling pathway to reduce the sensitivity of gastric cardia cancer to 5-FU.
Article in Journal of clinical biochemistry and nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastric cardia adenocarcinoma (GCA), an aggressive gastric cancer with rising incidence and poor prognosis, often requires chemotherapy and surgery. This study aimed to explore the regulatory mechanism of ZNF649 on 5-FU sensitivity in GCA. ZNF649 expression in GCA was analyzed using The Cancer Genome Atlas (TCGA) database. The relationship between ZNF649 expression and methylation level was analyzed using MethylMix and MethPrimer. GCA data was used to predict ZNF649-related signaling pathways via gene set enrichment analysis (GSEA). qPCR, western blot, and immunohistochemistry were used to detect ZNF649 expression at mRNA and protein levels. MSP was used to detect ZNF649 methylation in clinical samples. Cell viability and apoptosis were assessed by CCK8 and flow cytometry. ZNF649 was downregulated in GCA tissues and cells, negatively correlating with DNA methylation in its promoter. Overexpressing ZNF649 increased GCA cell sensitivity to 5-FU, lowering IC50 values and enhancing apoptosis. ZNF649 negatively regulated the Hedgehog pathway. Knocking down ZNF649 activated Hedgehog signaling, reducing 5-FU sensitivity. DNA methylation silences ZNF649, activating the Hedgehog pathway and weakening GCA cell sensitivity to 5-FU. Targeting ZNF649 and the Hedgehog pathway may overcome 5-FU resistance in GCA patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.